Key points are not available for this paper at this time.
Abstract Reducing the defect density of perovskite films during the crystallization process is critical in preparing high‐performance perovskite solar cells (PSCs). Here, a multi‐functional molecule, 3‐phenyl‐4‐aminobutyric acid hydrochloride (APH), with three functional groups including a benzene ring, ─NH 3 + and ─COOH, is added into the perovskite precursor solution to improve perovskite crystallization and device performance. The benzene ring increases the hydrophobicity of perovskites, while ─NH 3 + and ─COOH passivate defects related to I − and Pb 2+ , respectively. Consequently, the power conversion efficiency (PCE) of the optimal device increased to 24.65%. Additionally, an effective area of 1 cm 2 with a PCE of 22.45% is also prepared using APH as an additive. Furthermore, PSCs prepared with APH exhibit excellent stability by 87% initial PCE without encapsulation after exposure at room temperature under 25% humidity for 5000 h and retaining 70% of initial PCE after aging at 85 °C in an N 2 environment for 864 h.
Building similarity graph...
Analyzing shared references across papers
Loading...
Danyang Qi
Ministry of Education
Yang Cao
University of Connecticut
Xiaolong Feng
Chinese Academy of Medical Sciences & Peking Union Medical College
Small
Chinese Academy of Sciences
University of Chinese Academy of Sciences
Dalian Institute of Chemical Physics
Building similarity graph...
Analyzing shared references across papers
Loading...
Qi et al. (Mon,) studied this question.
synapsesocial.com/papers/68e6936db6db64358761a54f — DOI: https://doi.org/10.1002/smll.202401487
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: